Glioblastoma survival

Glioblastoma survival

Glioblastoma overall survival.

Glioblastoma patients who were readmitted within 30 days had significantly shorter survival than nonreadmitted patients. Future studies that attempt to decrease readmissions and evaluate the impact of reducing readmissions on patient outcomes are needed 2).

Despite advances in treatment, the median patient survival is 12 to 15 months 3).


Halaj M, Kalita O, Tuckova L, Hrabalek L, Dolezel M, Vrbkova J. Life expectancy in glioblastoma patients who had undergone stereotactic biopsy: a retrospective single-center study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023 Jul 10. doi: 10.5507/bp.2023.030. Epub ahead of print. PMID: 37431620.

Nuño M, Ly D, Ortega A, Sarmiento JM, Mukherjee D, Black KL, Patil CG. Does 30-Day Readmission Affect Long-term Outcome Among Glioblastoma Patients? Neurosurgery. 2014 Feb;74(2):196-205. doi: 10.1227/NEU.0000000000000243. PubMed PMID: 24176955.

DeAngelis LM. Brain tumors. N Engl J Med. 2001;344(2):114–123.

Leave a Reply